About
Kate Antrobus is a global health professional and financier with over 15 years of experience expanding access to medical technologies in emerging markets. She has held senior roles at Univercells, where she worked on biomanufacturing for vaccines and biologics, and at Lion's Head Global Partners advising on blended-finance strategies for health systems in low- and middle-income countries; she was also part of the investment team at the Global Health Investment Fund and started her finance career at J.P. Morgan. At Adjuvant she supports portfolio strategy, partnerships, and industrialization models to expand access to health products, focused on deploying capital in sub-Saharan Africa.
Invests in
BiotechDigital HealthImpact & Social Good
Experience
- BluesquareBoard Membercurrent2026 — present
- Adjuvant CapitalOperating Partnercurrent2025 — present
- Campaigns in Global HealthChair of the Board of Trusteescurrent2023 — presentCambridge, England, United Kingdom
- Medicines Development for Global HealthMember of the Board of Directors, Chair UK Entitycurrent2020 — present
- UNIVERCELLSChief Business Officer2023 — 2025Brussels, Brussels Region, Belgium
- UNIVERCELLSChief Investment Officer2021 — 2025Brussels, Brussels Region, Belgium
- UNIVERCELLSGlobal Health & Finance Lead2019 — 2021Brussels Area, Belgium
- Quantoom BiosciencesMember of the Board of Directors2021 — 2025
- EXOTHERAMember of the Board of Directors2021 — 2025
- UNIZIMAMember of the Board of Directors2021 — 2025
- Lion's Head Global PartnersExecutive Director2014 — 2018
- Stop TB PartnershipBoard Member (Private Sector Constituency)2017 — 2018
- J.P. Morgan Asset ManagementPortfolio Analyst2012 — 2014
Skills & more
Communication1Marketing1Strategic Thinking1Marketing StrategyBusiness DevelopmentCorporate DevelopmentBoard of Directors
- Chartered Financial Analyst (CFA) — CFA Institute
From Kate's professional profile.
Colleagues at Adjuvant Capital
Abrar Haque
Associate at Adjuvant Capital
Alexandra (Sandra) Glucksmann
Advisory Partner at Adjuvant Capital
Christian Mandl
Senior Advisor at Adjuvant Capital
Curt LaBelle
Venture Partner at Adjuvant Capital
Evelyn Yanatos
Director of Finance and Compliance at Adjuvant Capital
Gerard Cunningham
Operating Partner at Adjuvant Capital
Giulia Balconi
Associate at Adjuvant Capital
Glenn Rockman
Co-Founder and Partner at Adjuvant Capital
Frequently asked questions
- Who is Kate Antrobus?
- Kate Antrobus is a global health professional and financier with over 15 years of experience expanding access to medical technologies in emerging markets. She has held senior roles at Univercells, where she worked on biomanufacturing for vaccines and biologics, and at Lion's Head Global Partners advising on blended-finance strategies for health systems in low- and middle-income countries; she was also part of the investment team at the Global Health Investment Fund and started her finance career at J.P. Morgan. At Adjuvant she supports portfolio strategy, partnerships, and industrialization models to expand access to health products, focused on deploying capital in sub-Saharan Africa.
- Where does Kate Antrobus work?
- Kate Antrobus is Operating Partner at Adjuvant Capital.
- What does Kate Antrobus invest in?
- Kate Antrobus invests in Biotech, Digital Health, Impact & Social Good.
- Where did Kate Antrobus go to school?
- Kate Antrobus studied at University of Oxford (Bachelor of Arts - BA, Political Science and Government); Columbia University; The London School of Economics and Political Science (LSE).
Same school
Also attended University of Oxford1,229
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index Ventures
+ 1,223 more
Also attended Columbia University895
Ben HorowitzCo-founder & General Partner at Andreessen HorowitzDoug LeonePartner at Sequoia Capital; former Global Managing PartnerChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzKai-Fu LeeChairman of Sinovation Ventures and CEO of 01.AIGabriella GiglioHR & Executive Talent at General CatalystScott BillerInvestor at GV (Google Ventures)
+ 889 more
Also attended The London School of Economics and Political Science (LSE)1,362
Masayoshi SonFounder, Chairman & CEO of SoftBank GroupLee FixelFounder of AdditionPat GradyPartner at Sequoia CapitalNeil MehtaCo-founder & Managing Partner at GreenoaksCyriac ParisotInvestor at Index VenturesSofia DolfeInvestor at Index Ventures
+ 1,356 more
Shared employers
Also worked at Bluesquare1
Also worked at UNIVERCELLS1
Also worked at Lion's Head Global Partners4
Also worked at J.P. Morgan Asset Management49
Ralph DeBernardoPartner, Investor Relations at Sapphire VenturesAnna OglodzinskaExecutive Assistant at Sapphire VenturesNatalie EphraimProgram Manager – Mentorship & Partnerships at The Innovation SpaceMaxim OwenPartner at Wavemaker Three-Sixty HealthMichael HuttenPartner at Pantheon VenturesGraeme KeenanPartner at Pantheon Ventures
+ 43 more